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ABSTRACT
Elastin, the main component of elastic fibers, is synthesized only in early life and provides
the blood vessels with their elastic properties. With aging, elastin is progressively degraded,
leading to arterial enlargement, stiffening, and dysfunction. Also, elastin is a key regulator
of vascular smooth muscle cell proliferation and migration during development since het-
erozygous mutations in its gene (Eln) are responsible for a severe obstructive vascular dis-
ease, supravalvular aortic stenosis, isolated or associated to Williams syndrome. Here, we have
studied whether early elastin synthesis could also influence the aging processes, by compar-
ing the structure and function of ascending aorta from 6- and 24-month-old Eln/ and
Eln/ mice. Eln/ animals have high blood pressure and arteries with smaller diameters
and more rigid walls containing additional although thinner elastic lamellas. Nevertheless,
longevity of these animals is unaffected. In young adult Eln/ mice, some features resem-
ble vascular aging of wild-type animals: cardiac hypertrophy, loss of elasticity of the arterial
wall through enhanced fragmentation of the elastic fibers, and extracellular matrix accumu-
lation in the aortic wall, in particular in the intima. In Eln/ animals, we also observed an
age-dependent alteration of endothelial vasorelaxant function. On the contrary, Eln/- mice
were protected from several classical consequences of aging visible in aged Eln/ mice,
such as arterial wall thickening and alteration of 1-adrenoceptor-mediated vasoconstriction.
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INTRODUCTION
ELASTIC FIBERS, MADE OF 90% elastin and 10%microfibrils, represent more than 50% of
the ascending aorta dry weight.1 They are or-
ganized into circumferentially oriented lamel-
lar units, that is, concentric elastic lamellae al-
ternating with vascular smooth muscle cell
layers (VSMC).2 By circumferential stretching,
the elastic fibers of large arteries store part of
the energy delivered by the ejected blood vol-
ume during systole, and they release this en-
ergy during the diastole by returning to their
initial dimension. This is crucial for smooth-
ing blood flow and pressure.3 Nevertheless,
during the course of life, elastic fibers are pro-
gressively fragmented and lose their initial
mechanical properties. This process, leading
to a series of cellular and extracellular alter-
ations and vascular dysfunctions, is probably
the major contributor to the structural and
functional alterations defining normal vas-
cular aging4 (i.e., symptoms not related to
specific diseases such as atherosclerosis or
aneurysms). First, enzymatic cleavage of elas-
tic fibers occurs progressively in normal
vascular aging. The elastic fiber/lamella frag-
mentation leads to increases in arterial
diameter and stiffness, as well as production
of vasoactive elastin peptides.5–8 Lipid and
calcium deposition on arterial elastic fibers
also enhances the wall stiffening caused by
fragmentation and may contribute to the pro-
gression of cardiovascular dysfunction.5,9 An-
other major feature of aging is the increased
arterial wall thickness, which compensates for
the effects of the elevated stress in the wall
due to altered elastic fiber structure and he-
modynamics, including elevated blood pres-
sure.9 Finally, vascular cell function is also al-
tered in normal aging, leading to a reduced
response of vascular smooth muscle cells to
adrenergic vasoconstrictors10 and a reduced
production of the vasodilator NO by endo-
thelial cells.11
To understand if elastin could regulate some
of the structural and functional age-related/
late-onset arterial changes, we have investi-
gated whether an initial/genetic difference in
vascular elastin quantity and organization
could modify the course of arterial aging. To
support this hypothesis, it was already known
that elastin haploinsufficiency causes early-on-
set changes in the structure/function of the
cardiovascular system. Supravalvular aortic
stenosis (SVAS), isolated or in the setting of
Williams syndrome, is an obstructive vascular
disorder associated with heterozygous muta-
tions/deletions in the elastin gene, leaving only
a single functional allele. This pathology fea-
tures, in humans, ascending aorta lumen nar-
rowing due to deregulated hyperproliferation
of VSMCs in the subendothelium, additional
thinner elastic lamellae, abnormal mechanical
properties of arteries, often increased blood
pressure, and heart hypertrophy and failure, 
if not corrected.12–14 Also, elastin-null mice
(Eln/) develop smaller blood vessels, al-
most occluded by proliferating VSMCs, and die
within 72 h after birth.15 Eln/ mice survive
until adulthood although, similar to SVAS pa-
tients, they are hypertensive and have an aor-
tic wall with an increased number of elastic
lamellae that are two-fold thinner than in the
Eln/ animals, both modifications leading to
increased arterial stiffness.14 Hypertension,
correlated with high circulating renin levels,
could be a physiological adaptation allowing
Eln/ mice to maintain normal blood flow,
despite a stiffer arterial wall.16
These observations showed that qualitative
and quantitative defects in elastin expression
contribute to structural alterations and dys-
functions during arterial morphogenesis and
maturation. To study whether elastin quantity
can also induce late-onset arterial changes, we
selected Eln/ mice, which, although stable
and nonpathologic, present elastin haploinsuf-
ficiency and a different cardiovascular system
already in young animals.14,16 In these animals,
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Our results suggest that early elastin expression and organization modify arterial aging
through their impact on both vascular cell physiology and structure and mechanics of blood
vessels.
we have studied the structure and mechanical
properties of a large elastic artery, the ascend-
ing aorta, and the cardiac function in aging. Our
results suggest that early elastin deficiency in
Eln/ mice induces long-term changes in ar-
terial physiology, resulting in modifications of
some of the major features of vascular aging.
MATERIALS AND METHODS
Animals
Eighty Eln/ male mice (C57Bl/6J) or
mice bearing a heterozygous deletion of exon
1 in the elastin gene (Eln/), which leads to
a nonfunctional allele, were backcrossed for
more than five generations into the C57Bl/6J
background and used in these experiments.14,15
Studies were performed in two age groups:
adults, 5–7 months old (6 months  adults);
and aged, 23–27 months (24 months  aged).
Littermates from Eln/ crosses were used
whenever possible. All housing and surgical
procedures were in accordance with institu-
tional guidelines.
Blood pressure measurements and heart weight
Mice were anesthetized by intraperitoneal
(i.p.) injection of 60 mg/kg ketamine (Merial,
Lyon, France) and 6 mg/kg xylazine (Bayer,
Puteaux,  France) and placed on a heating table
to maintain body temperature at 37°C. Mean ar-
terial pressure was measured by inserting in the
carotid artery a small catheter (Portex, Smiths
Medical International Limited, Watford, United
Kingdom) filled with a heparinized saline solu-
tion and connected to a pressure transducer
(P23ID, Gould Instrument Co., Cleveland, OH).
In other animals, anesthetized with pento-
barbital (60 mg/kg, i.p.), hearts and left ven-
tricles were dissected, washed, and weighed
(wet weight).
Untrasound study
Ultrasound studies were performed as pre-
viously described,17,18 using a Toshiba Pow-
ervision 6000 device (SSA 370A, Toshiba, Med-
ical France S.A., Puteaux, France) equipped
with an 8- to 14-MHz linear transducer under
isoflurane anesthesia (0.75–1.0% in oxygen)
with spontaneous ventilation. In vivo ascend-
ing aorta systolic and diastolic diameters were
measured from time-mode imaging as gated on
R wave from simultaneous ECG tracing.
Arterial desmosine and hydroxyproline contents
Desmosine levels, considered as representa-
tive of the elastin content, were determined by
radioimmunoassay, as described previously.19
Hydroxyproline levels, considered as repre-
sentative of the collagen content, were deter-
mined by amino acid analysis using standard
techniques.20 Results are expressed as amino
acid mass per vessel segment length.
Cannulated aorta mechanics
Mechanical studies were performed on can-
nulated ascending aortas excised from mice
anesthetized by intraperitoneal injection of
pentobarbital (60 mg/kg). The inner and outer
diameters were measured at different pres-
sures upon inflation using a physiological so-
lution. Below 125 mmHg, the inner diameter
was calculated as described previously.16
Distensibility is the change in relative lumi-
nal volume (percentage) per mmHg.21 Here we
calculated the distensibility per 25 mmHg in-
crement (D25).16
Circumferential midwall strain (), circum-
ferential wall stress (), and incremental elas-
tic modulus (E) were calculated according to
classic formulas22: , relative increase in di-
ameter at a given pressure as compared to the
diameter at no pressure; , forces that are cir-
cumferentially applied on a each small por-
tion (surface) of the vessel wall; E, wall stiff-
ness.
Cannulated aorta reactivity
Variations of the ascending aorta diameters
in response to 5 mol/L phenylephrine (PE), a
VSMC-dependent vasoconstrictor mainly act-
ing through the alpha1-adrenoceptors, then 5
mol/L acetylcholine (Ach), an endothelial
cell–dependent vasodilator, was assessed at 75
mmHg.16 Control diameters of Eln/ mouse
aortas before PE application were normalized
to the mean control diameter of Eln/ mouse
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aortas prior to comparisons of the effect of
treatment as a function of genotype.23
Histological examination
Vessels excised from anesthetized mice were
fixed overnight in 4% paraformaldehyde (PFA)
at 4°C and processed for paraffin embedding.
Transverse sections (3m) of the ascending
aorta were stained with hematoxylin-eosin for
cells staining, Weigert for elastic fibers, and pi-
crosirius red for collagen.
Ultrastructure—transmission electron microscopy
Ascending aortas were routinely fixed by
cardiac perfusion with 2.5% glutaraldehyde in
0.1 M sodium cacodylate buffer (pH 7.4), then
embedded in Epon for ultrastructural analyses.
Sections were stained according to a previously
described method,24 or pretreated with tannic
acid before uranyl acetate staining. Sections
were examined on a JEM 1200 EX II (Jeol,
Tokyo, Japan) electron microscope at an accel-
erating voltage of 80 kV.
Expression of tropoelastin, lysyl-oxidase, lysyl-
oxidase-like-1, fibrillin-1, fibrillin-2, fibulin-5,
and type I collagen in the mouse aorta
RNA isolation and reverse transcription
from entire aortas was performed according to
the classic method.25 The yield of total RNA
from a single ascending aorta was typically
2.9–7.5 g. Gene expressions were evaluated by
real-time PCR using a Light-Cycler with the
FastStart DNA Master SYBR Green Kit (Roche
Diagnostics, Meylan, France) after mRNA re-
verse transcription of 400 ng total RNA in the
presence of oligodT, then normalized to the
housekeeping gene beta-actin. Measured tran-
script levels were reproducible at levels that
were significantly above background. Oligo
primers used were:
-tropoelastin (TE): 5-AAGCTGCTGCTAAG-
GCTGC-3 (antisense) and 5-TGCAACTCC-
TCCACCTGGGAA-3 (sense),
-lysyl-oxidase (LOX): 5-AATTCAGCCACT-
ATGACCTGCTTGA-3 (antisense) and 5-
GTAGCGAATGTCACAGCGTACAACA-3
(sense),
-lysyl-oxidase-like-1 (LOXL1): 5 CAGCTTCT-




GA-3 (antisense) and 5-TGGCGAGGCT-
CACGTTGGCTT-3 (sense),
-fibrillin-2: 5-AGTAGCCGCAACCTCGTCAC-
AAA-3 (antisense) and 5-AGCACTGGTA-
ACTGCCCTTGGTGT-3 (sense),
-fibulin-5: 5-ATATCAATGAATGTGAGCA-
CC-3 (antisense) and 5-GTTGATGACAGT-
GTTGACAGTGAT-3 (sense),
-type I collagen: 5-GTTCGTGACCGTGAC-
CTTGA-3 (antisense) and 5-GGTGAAGC-
GACTGTTGCCT-3 (sense),




mRNA expressions were normalized to the
housekeeping gene beta-actin, amplified using
the following primers: 5-TGGAATCCTGTGG-
CATCCATGAAAC-3 (antisense) and 5-TAA-
AACGCAGCTCAGTAACAGTCCG-3 (sense).
Statistics
Comparisons, as a function of age, of
Eln/ and Eln/ body weight, heart
weight/body weight ratios, heart rate, mean
blood pressure, ultrasonography parameters,
mRNA dosages, desmosine and hydroxypro-
line contents and their ratios, electron mi-
croscopy image analysis, and vessel diameters
(OD and ID) in response to vasoactive agonists
were assessed using two-way ANOVA, fol-
lowed when necessary by Fisher’s least signif-
icant difference test (LSD) or t-test for paired
value comparisons. Vessel diameters were
compared as a function of transmural pressure
level (0–175 mmHg), KCN treatment (before or
after), genotype (Eln/ or Eln/), and age
(6- or 24-month-old) using a four-way ANOVA
followed when necessary by LSD tests. Vessel
midwall strain, stress, incremental elasticity
modulus, distensibility, and local midwall
strain comparisons were assessed using the
nonparametric Mann-Whitney U test. Unless
otherwise indicated, the results are presented
as mean values  standard error of the mean
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No significant difference in life span was ob-
served between Eln/ and Eln/ mice
(Chi2 test, P  0.227) (Fig. 1A). Eln/ mice
were found substantially hypertensive through-
out adulthood and aging, with a mean arterial
pressure increased by 20–30% when compared
to Eln/ animals, although no difference 
in heart rate could be detected. No age-depen-
dent increase in blood pressure was observed
(Table 1).
Body weights were found similar in all animal
groups (33–36 g), yet heart weight increased with
age in both genotypes (25%). Cardiac hyper-
trophy was observed in adult and aged Eln/
mice, with left ventricles 15% heavier. The
heart weight of adult Eln/ mice was the same
as those of aged Eln/ animals (Table 1).
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FIG. 1. Effect of aging and genotype on the survival rate (A), length of the ascending aorta of 6- and 24-month-old
Eln/ and Eln/ mice (B), and histological examination of paraffin-embedded cross-sections of the ascending
aorta of 6- and 24-month-old Eln/ and Eln/ mice (C). (a–d) eosin/hematoxylin; (e–h) Weigert ; and (i–l) pi-
crosirius red stainings (For color version, see <www.liebertonline.com/rej>.). Bar sizes: 200 m (a–d) and 50 m (e–l).
In each group, n  39–50 (A) and n  4–5 (B). lm, lumen; d, distal; p, proximal.
Histology and ultrastructure of the ascending
aorta wall
The ascending aorta length was significantly
increased by aging (23–30% in both geno-
types) and elastin haploinsufficiency (20–
26% at both ages): 2.57  0.15 vs. 3.24  0.14
mm in adults, and 3.34  0.23 vs. 4.00  0.17
mm in aged Eln/ and Eln/ mice, re-
spectively (two-way ANOVA, p  0.05) (Fig.
1B). In Eln/- mice, the arterial diameter was
decreased (Table 1, Fig. 1C). Two to three ad-
ditional lamellar units were present compared
to wild-type animals while, within each geno-
type, aging had no effect on the number of elas-
tic lamellae (Fig. 1C): 8.8  0.4 vs. 11  0.1
lamellae in adults, and 8.6  0.3 vs. 10.7  0.0
in aged Eln/ and Eln/ mice, respec-
tively (two-way ANOVA, p  0.05).
Ascending aorta semi-thin sections (data not
shown) and electron microscopy images
showed that in Eln/ mice at both ages: (1)
elastic lamellae were thinner, (2) the distance
between successive lamellae was shorter, and
(3) elastic lamellae were more fragmented or
branched, with irregular contours, compared to
Eln/ elastic lamellae (fragmentation was
similar in adult Eln/ and aged Eln/
mice) (Figs. 2A[c,d], 2B[c,d], 3A(C). Moreover,
the distance between elastic lamellae signifi-
cantly increased with age in Eln/ mice
only, but not in Eln/ animals (Fig. 3B). Also,
thickness of the vascular smooth muscle cell
layers was increased more significantly with
age in Eln/ (55%) than in Eln/ mice
(19%) (Fig. 3D).
In Eln/ animals, picrosirius red staining
suggested a more dispersed distribution of col-
lagen in the aorta wall (Fig.1C), and unusual
elastin deposits were observed in the margin of
elastic lamellae (Fig. 2A and 2B[b,d]). Also, in
animals from both genotypes, aging was cor-
related with an increase in cytoplasmic extru-
sions due to cell stretching and accumulation
of extracellular matrix (ECM), which tends to
make more discontinuous the contacts between
elastic lamellae and vascular cells. ECM accu-
mulation, however, was limited to the media
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TABLE 1. PHYSIOLOGICAL PARAMETERS AND CARDIOVASCULAR ULTRASOUND STUDY OF 6- 
AND 24-MONTH-OLD ELN AND ELN MICE. IN EACH GROUP, N  12–13 
FOR BODY AND HEART WEIGHTS AND N  4 FOR MEAN ARTERIAL PRESSURE
6 month-old mice 24 month-old mice
Eln Eln Eln Eln
BW (g) 36.0  1.1 35.3  1.3 35.3  0.8 33.0  1.0
Heart weight/BW (%) 0.43  0.01 0.50  0.02G 0.53  0.03A 0.62  0.02G
Left ventricle/BW (%) 0.35  0.01 0.40  0.02G 0.43  0.02A 0.49  0.02G
Mean arterial pressure (mmHg) 103  11 123  2G 107  4 138  8G
Ultrasound study:
Number of animals 5 4 10 9 
Systolic aorta diameter (mm) 1.95  0.08 1.68  0.10G 2.24  0.15 1.85  0.13G
Diastolic aorta diameter (mm) 1.8  0.07 1.54  0.10G 2.12  0.15 1.75  0.13G
Heart rate (beats per minute) 504  11 499  3 508  16 496  17
LVEDD/BW (mm) 0.11  0.002 0.12  0.01 0.12  0.01 0.13  0.01
Left atrium dimension-La (mm) 3.14  0.05 3.17  0.14 3.26  0.20 3.00  0.14
Shortening fraction-FS (%) 41  3 41  2 40  5 39  3
Vcfc (circ/s) 2.80  0.20 2.70  0.20 3.01  0.29 3.00  0.16
Sa (cm/s) 3.5  0.3 3.1  0.2 2.8  0.4 2.7  0.3
Spw (cm/s) 3.80  0.10 3.60  0.30 3.60  0.20 2.97  0.40
Isovolumic relaxation time (ms) 15.0  0.5 17.0  3.0 19.5  0.7A 17.5  1.5
Ea (cm/s) 4.3  0.3 5.3  0.5 4.1  0.3 5.3  0.4
Epw (cm/s) 4.1  0.3 4.6  0.2 5.0  0.6 4.1  0.4
E/Ea 25.0  6.0 20.0  3.0 25.0  2.3 19.0  2.1
ASignificant difference with adult animals of the same genotype.
GSignificant difference with Eln animals of matching age.
BW, body weight; LVEDD, left ventricle end diastolic diameter; Vcfc, mean shortening velocity of circumferential
fibers, corrected for time; Sa, Spw: maximal systolic velocity of the mitral annulus and posterior wall, respectively.
Ea, Epw: maximal diastolic velocity of the mitral annulus and posterior wall, respectively. E/Ea: maximal velocity of
LV mitral inflow to Ea.
in wild-type mice, whereas it was present in
both the media and the intima in the aorta of
Eln/ animals. As a consequence, the endo-
thelial cells, which lied on a basement mem-
brane directly connected to the internal elastic
lamina (IEL) in Eln / arteries, were clearly
separated from the IEL by a subendothelial ac-
cumulation of ECM and had a basal side which
turned to crenelated in Eln/ mice. A simi-
lar phenomenon increased the distance be-
tween the IEL and the first medial layer of
smooth muscle cells in Eln/ animals (Figs.
2A[a,b], 2B[a,b], 3E-F).
Desmosine and hydroxyproline contents in the
ascending aorta
The contents of desmosine and hydroxypro-
line remained constant with age in both geno-
types. However, it was observed at both ages
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FIG. 2. Transmission electron microscopy images of the ascending aorta in mice aged of 6 (A) and 24 months (B).
(a,c) Eln/; (b,d) Eln/; (a,b) intima; (c,d) media. Arrows, disruptions of the elastic lamella; asterisks, elastin de-
posit in margin of elastic lamellas; squares, subendothelial accumulation of extracellular matrix; endo, endothelium;
el, elastic lamella; lm: lumen; smc, smooth muscle cell. Bar size: 1 m.
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FIG. 3. Morphometric analysis of the transmission electron microscopy images of the ascending aorta in Eln/
and Eln/ mice aged of 6 (adult) and 24 months (old). Thickness of the elastic laminae (A), distance between suc-
cessive elastic laminae (B), fragmentation of elastic laminae (C), thickness of VSMC layer (D), distance between the
internal elastic lamina (IEL) and endothelial cells (EC) (E) or smooth muscle cells (SMC) (F). Number of measure-
ments performed on different sections from several animals in each group: 89 (A), 102 (B), 20 (C), 57 (D), 64 (E), 75
(F). #significant difference compared to adult animals of matching genotype. Two-way ANOVA: *general effect of





that, while hydroxyproline content was similar
in mice of both genotypes, desmosine content
and desmosine/hydroxyproline ratios were
about 40–50% lower in Eln/ than in
Eln/ ascending aortas (Fig. 4A-C). How-
ever, the desmosine/hydroxyproline ratios
were unchanged by aging within each geno-
type (Fig. 4C).
Extracellular matrix gene expression
The expression of the following genes in-
volved in elastic fiber assembly were investi-
gated: tropoelastin (the elastin precursor),
lysyl-oxidase, lysyl-oxidase-like-1, fibrillin-1,
fibrillin-2, and fibulin-5. The expression levels
of all these genes were generally low in adult
and aged animals (i.e., several fold lower than
in growing animals [data not shown]). Tropoe-
lastin and fibrillin-2 showed particularly low
expression levels at both ages. The expression
levels of all the genes studied, with the excep-
tion of tropoelastin, decreased with age inde-
pendently of the genotype. Only two genotype-
related differences were noticed: significantly
less collagen-I and fibrillin-2 were expressed in
ascending aortas of 6-month-old Eln/ mice
compared to that of wild-type animals of
matching age, while no genotype-related dif-
ference could be detected in 24-month-old an-
imals. The expression of collagen-I and fib-
rillin-2 in adult Eln/ mice was close to the
levels observed in aged Eln/ animals (Fig.
4D). In addition, no significant difference in the
expression of endothelial nitric oxide synthase
(eNOS) could be detected between all groups
of mice (Fig. 4E).
In vivo cardiovascular function
Functional characterization by echocardiog-
raphy in anesthetized mice showed left ventri-
cle and left atrium enlargement in Eln/- mice.
No significant differences were found for left
ventricle contractility and diastolic function
(Table 1), except for isovolumic relaxation 
time, which normally increased with age26 in
Eln/ mice (30%), but not in Eln/ an-
imals. In vivo ascending aorta diameters were
assessed in anesthetized mice at the time of
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FIG. 4. Desmosine and hydroxyproline contents and ratios (A–C), and gene expressions quantified by real-time PCR
(D and E) in the ascending aorta of 6- and 24-month-old Eln/ and Eln/ mice. ELN, tropoelastin; COL1A1, 1
chain of collagen-I; LOX, lysyl-oxidase; LOXL1, lysyl-oxidase-like-1; FBN1, fibrillin-1; FBN2, fibrillin-2; FBLN5, fibu-
lin-5; eNOS, endothelial nitric oxide synthase.*, , 	Significant difference between Eln/ and Eln/ mice of
matching age, between 6- and 24-month-old Eln/ mice, and between 6- and 24-month-old Eln/ mice, respec-




FIG. 5. Diameter pressure curves and derived mechanical parameters of the ascending aorta of 6- and 24-month-
old Eln/ and Eln/ mice. *,Significant difference between 6-month-old Eln/ and Eln/ mice or between
24 month-old Eln/ and Eln/ mice, respectively. ,	Significant difference between 6 month-old and 24 month-
old values for Eln/ and Eln/ mice, respectively. §Significant difference between Eln/ and Eln/ of






echocardiography. Systolic and diastolic diam-
eters of the ascending aorta were smaller
(15%) in Eln/ as compared to Eln/
animals, at both ages (Table 1).
Dimensions and mechanics of the cannulated
ascending aorta
Study of cannulated vessels confirmed that
in adult and aged animals the Eln/ as-
cending aorta has a smaller diameter than does
the Eln/ at any given pressure (Fig. 5A).
However, when compared at their respective
in vivo mean arterial pressures (100 and 125-
135 mmHg for Eln/ and Eln/, respec-
tively), the diameters were similar between
Eln/ and Eln/ animals at both ages. It
was also observed that aging in both genotypes
leads to a general increase in inner diameter,
except at the highest pressures where the max-
imum diameters of mice of a given genotype
tend to be similar at both ages, or perhaps
slightly decreased in wild-type animals (Fig.
5A).
Distensibility (D25) generally decreased with
pressure in all animals. In adult Eln/ ani-
mals, distensibility was increased at low intra-
luminal pressure and decreased at the highest
pressures compared to that of Eln/ mice,
whereas aorta distensibility was almost identi-
cal in aged animals of both genotypes over the
entire pressure range. Compared to adults,
aged animals of both genotypes presented
elevated aortic distensibility at low pressure
and faster distensibility drop with increasing
pressure. At the highest pressures, including
physiological/working blood pressures, aged
Eln/ aortas presented a distensibility that
was only slightly changed compared to that of
adult Eln/ vessels, whereas the distensibil-
ity of aged Eln/ aortas was substantially
decreased compared to that of adult Eln/
arteries (Fig. 5B).
Despite an increased number of elastic lamel-
lae, the aorta wall thickness of Eln/ mice
was not increased (Fig. 5C) because of the de-
creased lamina thickness and interlamellar dis-
tance (Fig. 3A and B). The evolution with age
of ascending aorta wall thickness was surpris-
ingly different in Eln/ and Eln / mice.
In adults, the wall thickness of Eln/ mice
was not increased and even slightly lower than
that of Eln/ animals. In the older mice, the
wild-type animals exhibited a classic and sub-
stantial age-dependent increase in wall thick-
ness, while no wall thickening was observed
with aging in Eln/ animals.
Elastin haploinsufficency and aging also had
an influence on aorta mechanical parameters
(Fig. 5D-G). At the respective in vivo blood
pressures of Eln/ and Eln/ mice: (1) cir-
cumferential midwall strain (
) was higher in
Eln/ than in Eln/ adult mice and was
similar in both genotypes in aged animals (Fig.
5D); (2) circumferential wall stress () was ele-
vated in Eln/ mice at both ages (Fig. 5E),
(3) with age, aortic stress was decreased in
Eln/ and increased in Eln/- mice when
  0.8 (Fig. 5F); and (4) incremental elastic
modulus (E) was virtually unchanged by aging
in Eln/ animals, while a strong age-depen-
dent increase in E was observed in Eln/
mice above 100 mm Hg (Fig. 5G).
Ascending aorta reactivity
Response to the vasoconstrictor phenyle-
phrine (PE) was similar in adult animals of both
genotypes. However, a substantial age-depen-
dent decrease in PE-induced constriction
(50%) was observed in wild-type mice
while no age-related change could be observed
in Eln/ mice (Fig. 6A and B). When acetyl-
choline (Ach) was applied to the ascending
aorta, no difference in vasodilation was ob-
served between adult Eln/ and Eln/
mice. In aged mice, Ach-induced relaxation of
the aorta was found to be similar to that of
adults in wild-type animals, whereas it was sig-
nificantly reduced by approximately 25% com-
pared to adult animals in Eln/ mice (Fig.
6A and C).
DISCUSSION
Elastin is an essential determinant of arte-
rial morphogenesis.15 VSMCs hyperproliferate
when elastin is present in below normal levels,
leading to abnormal structure and function of
arteries. This has been documented in the
genetic diseases supravalvular aortic stenosis
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FIG. 6. Reactivity to vasoactive agents of the ascending aorta of 6- and 24-month-old Eln/ and Eln/ mice.
(A) 5 mol/L phenylephrine (PE) or 5 mol/L phenylephrine  5 mol/L acetylcholine (PE  Ach). PE-induced
vasoconstriction is also represented as the decrease in inner diameter, in percent of the control diameter (B), and Ach-
induced vasodilation is represented as the reversal of the PE-induced vasoconstriction, in percent (C). #Significant dif-
ference between control and post-treatment values at same age and genotype. , , 	,Significant difference for the
same treatment between Eln/ and Eln/ of matching ages, between 6- and 24-month-old Eln/, and between




or Williams syndrome.12,13,27 We previously
showed that Eln/ mice survive until adult-
hood, although they exhibit some features of
human disease such as hypertension, cardiac
hypertrophy, and, in arteries, an increased
number of elastic lamellae, increased stiffness,
and smaller diameters.16 In the present study,
we have investigated whether early modifica-
tions of the Eln/- mouse arterial structure
and function, resulting from elastin hemizy-
gosity, could have other consequences latter in
life and alter the normal cardiovascular aging
processes.
Our results indicated that some parameters
are similar in adult and aged Eln/ and
Eln/ animals: no difference in life span,
body weight, heart rate, and most cardiac func-
tional parameters. Elastic fiber-related gene ex-
pression was generally similar in the two geno-
types and decreased similarly with age in
Eln/ and Eln/ mice, except for tropoe-
lastin whose expression level did not signifi-
cantly vary between 6- and 24-months of age
in all animals.
We also found that some features are specif-
ically modified in the ascending aorta of adult
and aged Eln/ mice compared to Eln/
animals of matching ages. This includes de-
creased elastin content and elastin/hydroxy-
proline-containing collagen ratio, hyperten-
sion, and ascending aorta lengthening,
consistent with the previously described
carotid artery and abdominal aorta lengthen-
ing in Eln/ young mice.28 Vessels were
smaller in diameter at a given pressure and
there was a substantial subendothelial accu-
mulation of extracellular matrix (ECM) sepa-
rating the endothelial cells from the internal
elastic lamina. Further investigation may de-
termine whether this subendothelial ECM
accumulation corresponds to the increase in
fibronectin, proteoglycans, and collagen con-
tents (although no structured collagen was ob-
served here) occurring in the age-dependent in-
timal thickening observed in humans and
rats.29 Additionally, in Eln/ mice, the elas-
tic lamellae were thinner, increased in number,
and had irregular borders. Elastin droplet-like
structures, separate from the elastic lamellae,
were also observed and could correspond to ei-
ther abnormal longitudinally oriented elastic
lamellae or isolated non-structurally organized
and non-mechanically functional elastin de-
posited by deregulated VSMCs. Moreover, col-
lagen-I and fibrillin-2 expressions were lower
in adult Eln/ than in Eln/ mice, and a
surprizing reinduction of fibrillin-2 expression
was observed in aged Eln/ animals only.
Some cardiovascular alterations that appear
with age in wild-type animals were already
present in adult Eln/ animals. This in-
cluded cardiac hypertrophy, higher fragmen-
tation of the elastic lamellae than in Eln/
mice, and decreased aortic distensibility. In ag-
ing, these alterations were maintained or en-
hanced in Eln/ mice while they were just
appearing in Eln/ animals. Hence, these
specific features of adult Eln/ mice resem-
ble premature aging compared to Eln/
mouse aging. Conversely, other classic charac-
teristics of normal aging in wild-type animals
did not appear in aged Eln/ mice. In many
species, including mice and humans, normal
arterial aging features a dilation of the large
systemic and pulmonary arteries together with
a fragmentation of the elastic lamellae, and a
substantial wall thickening.9,30 This is consis-
tent with the age-dependent wall thickening
(40%) that we observed in Eln/ mice. In
Eln/ mice, aging-induced arterial dilation
and elastic lamellae fragmentation were also
observed yet no arterial wall thickening could
be detected. This is surprising, since age-re-
lated wall thickening, due to ECM accumula-
tion and VSMC hypertrophy, is an adaptive
compensatory mechanism for maintaining
close to normal circumferential forces, that is,
stress (stress  pressure  radius/thickness),
directed against the arterial wall. When blood
pressure and/or arterial radius increase with
age, stress would increase in the absence of
wall thickening. In the absence of wall thick-
ening, the age-dependent increase in blood
pressure and/or arterial diameter would lead
to increased wall stress. In aging Eln/ mice,
although no change in mean arterial pressure
(MAP) could be detected, the arterial diameter
substantially increased in the physiological
blood pressure range (100 mmHg) and the
wall thickened. These phenomena were prob-
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ably due to VSMC hypertrophy (55%) and
production of ECM and probably non-colla-
genic since there were no age-related increases
in hydroxyproline content and collagen-I ex-
pression in response to circumferential me-
chanical forces. In Eln/ mice, however,
there was a smaller age-dependent increase in
arterial diameter in their working range of
pressure (MAP, 125-135 mmHg) and stress did
not, or only slightly, increased with age. As a
result, there is no need for an increase in wall
thickness to maintain the wall stress at the level
measured in adults. Our results suggest that
the limited increase in aortic diameter in
Eln/ mice aging is caused by a lower age-
related VSMC hypertrophy (19%) and pre-
mature fragmentation of the elastic lamellae.
This degradation could decrease the role of
elastic fibers (elasticity/extensibility) and in-
crease the role of the collagen fibers (stiffness)
in Eln/ arteries. This would lead to stiffer
Eln/- vessels in adults, working at high
pressure close to their extensibility limit, re-
sembling the observations in aged Eln/ an-
imals. Finally, VSMC-dependent aorta con-
striction in response to alpha1-adrenoceptor
stimulation is classically decreased in normal
aging,10,31 potentially in relation with the de-
creased number of adrenergic receptors evi-
denced in several tissues: alpha1b-subtype in
the aorta,32 alpha-type in ventricular cells,33
and beta-type in blood cells.34 This is consis-
tent with our results in phenylephrine-treated
Eln/ aortas, whereas no such age-depen-
dent loss of response to this agonist was seen
in Eln/ mice. On the contrary, an age-re-
lated decrease in response to the endothelium-
dependent vasodilator acetylcholine was ob-
served in the aorta of Eln/ animals, but not
in Eln/ mice, suggesting a stronger age-de-
pendent dysfunction of the endothelium in
Eln/ mice.
Taken together, our results show that the
Eln/ mice do not present any major pathol-
ogy of the heart and aorta, and have a life span
similar to wild-type animals. This suggests that
genetic elastin deficiency can be efficiently
compensated for in adult and aged mice by dif-
ferent mechanisms, including VSMC prolifera-
tion and modified elastic fiber deposition, lead-
ing to production of additional elastic lamellae.
These processes result in a different state of the
cardiovascular physiology of Eln/ mice, in
which the combination of elevated blood pres-
sure and modified arterial mechanics and re-
activity does not affect life span. Our studies
expand to aging the concept that a decreased
deposition of insoluble elastin/elastic fibers
stimulates VSMC proliferative activity and
vascular changes, such as in SVAS or WS pa-
tients27 or fibulin-5 deficient mice.35 However,
in Eln/ mice, despite the enhanced VSMC
proliferation, the distance between successive
elastic lamellae was shorter than in Eln/
mice. This is explained by the fact that, in
Eln/ mice, VSMC proliferation does not
lead to accumulation of cells into the same cell
layer. The additional cells migrate to form sep-
arate/additional concentric cell layers and cor-
responding additional elastic lamellae.14 As a
consequence of the different morphologies of
the elastic lamellae and VSMCs, the inter-
lamellar distance and lamellar unit thickness
are even lower in Eln/ than in Eln/
mice, especially in aged animals.
In addition, the specific cardiovascular aging
features observed in Eln/ mice with high
blood pressure are not caused by early hyper-
tension-induced remodeling. Investigations in
humans or murine models show that hyper-
tension results in increased large artery diam-
eter and wall thickness, as well as mortal-
ity,9,30,36 which were not observed in Eln/
mice. It is likely then that particular maturation
and aging processes develop from the initial
and sustained elastin deficiency of Eln/ an-
imals. However, high blood pressure observed
in Eln/ mice is correlated to increased cir-
culating renin levels,16 and activation of the
renin-angiotensin system is known, in humans
and animals, to be a major effector of secondary
hypertension originating in renal artery ather-
osclerosis or other diameter narrowing, and
subsequent altered renal blood flow.37 More-
over, because atherosclerosis generally pro-
gresses in the elderly, the frequency of reno-
vascular hypertension increases with age,
reaching at least 7% of the human population
above age 65.38 It would therefore be interest-
ing to investigate the histology and function of
renal arteries in aging Eln/ mice to search
for the presence of processes leading to ele-
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vated blood pressure. The fact that patients
with Williams syndrome often present hyper-
tension and renal artery stenosis39 supports
this hypothesis. Also, hypertension and endo-
thelial dysfunction, present in Eln/ mice,
are known to favor cerebrovascular diseases
such as stroke and aneurysms in humans or an-
imal models.40–42 However, these pathologies
are probably not enhanced in Eln/ mice
since the life span of these animals was not de-
creased. Further investigation of the cerebral
arteries or microvasculature of Eln/ mice
could determine whether structural or func-
tional changes are present in these vessels.
Finally, our study suggests that there is not
a unique process for vascular aging, allowing
adaptive mechanisms leading to normal life
span (i.e., there is certain plasticity of aging).
As elastin is no longer synthesized in adult-
hood, the initial conditions established during
embryogenesis and early life (i.e., cardiovascu-
lar structure and function) determine the way
that arteries will evolve with age. In particular,
initial elastin quantity, quality, and organiza-
tion might have an impact on the VSMC func-
tions, including response to agonists, synthesis
activity, proliferation, and migration, and
could be a determinant of the events that will
occur later in life, dramatically changing the
consequences of aging on the arterial structure
and function.
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